If a institutional investor wants a $1M holding in FUSZ, it
If a institutional investor wants a $1M holding in FUSZ, it doesn't matter the number of shares they hold to them. No different if they wanted to buy $1M of gold. They should look at the current price and then figure out how many ounces they would purchase.
Today on the OTC we have 6 digit trades. Hard to believe, but it's happening. One could easily think, hey if a stock on the OTC is trading at .00001 cent at a time, it will take a life time to go up. Not the case.
On the NASDAQ with fewer shares, I believe the sp will move pennies, nickles and dimes in minutes and dollars in days and weeks.
12
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ensign Group's Recent Troubles Unraveled Let's set the scene: Ensign Group, once riding high at over $170 a share, finds itself knee-deep in allegations that'll make any investor squirm. Now, we're not just talking about a typical market fluctuation here – this is a real smackdown with an 8.2% drop, all thanks to some damning accusations. A Closer Look at Allegations...
Continue Reading
Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...
Continue Reading
Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...
Continue Reading
Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...
Continue Reading
Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...
Continue Reading
When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...
Continue Reading
A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...
Continue Reading
Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...
Continue Reading
Transforming Healthcare in South Africa and Ghana Expanding into uncharted territories often requires a leap of faith, and EASE Holdings has just taken a substantial one. The medical equipment-as-a-service provider has grabbed a hefty $9.5 million in equity from AAFC Group Inc. The goal? To flood South Africa and Ghana with cutting-edge medical imaging and surgical...
Continue Reading
Hudsonville's New Chapter: Enter CJ Ellens When a firm as storied as Hudsonville Ice Cream elects a new captain at the helm, folks sit up and take notice. CJ Ellens, already well-embedded in the fabric of Hudsonville, is set to steer the ship starting January 1, 2027. This isn't just a revolving door of C-suites, but more like a passing of the torch to someone bred in the...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Outdoor Spaces: Latham's Insights on Pool Trends As the pool industry progresses into a new era, homeowners are increasingly drawn to trendy designs and advanced technologies that redefine how swimming pools are perceived and used. The latest innovations are centered around increasing efficiency, enhancing aesthetics, and incorporating luxurious features into...
Continue Reading
National Grid Renewables Partners with Microsoft for Solar Power National Grid Renewables has recently completed a significant power purchase agreement (PPA) with Microsoft for its new 250-megawatt (MW) solar project. This initiative promises to harness clean energy while contributing positively to local economies. Investing in Solar Energy for a Sustainable Future The...
Continue Reading
Understanding the Recent Legal Developments for Iovance Biotherapeutics In recent news, a notable lawsuit has been filed involving Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), which has raised concerns among its investors. This legal action is significant, as it addresses potential violations of federal securities laws by the biopharmaceutical company and its senior...
Continue Reading
Decoding NetEase's P/E Ratio In the current trading session, NetEase Inc. NTES shares are priced at $132.28, reflecting a slight decline of 1.94%. Over the past month, the stock has faced a small decrease of 0.68%. However, on an annual scale, the stock has impressively increased by 47.12%. Investors observing short-term fluctuations may find themselves questioning the...
Continue Reading
IMAX Breaks Records During the Chinese New Year Celebration IMAX Corporation (NYSE: IMAX) has made headlines by achieving an unprecedented box office milestone during the Chinese New Year, raking in an impressive $53 million over the holiday period that concluded recently. This surpasses their previous record of $34 million set just a year prior, marking a staggering 57%...
Continue Reading